- Home
- OKYO vs APYX Comparison
OKYO vs APYX Comparison
Compare OKYO & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- APYX
- Stock Information
- Founded
- OKYO 2007
- APYX 1982
- Country
- OKYO United Kingdom
- APYX United States
- Employees
- OKYO N/A
- APYX N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- APYX Medical/Dental Instruments
- Sector
- OKYO Health Care
- APYX Health Care
- Exchange
- OKYO Nasdaq
- APYX Nasdaq
- Market Cap
- OKYO 37.0M
- APYX 36.8M
- IPO Year
- OKYO 2022
- APYX 1987
- Fundamental
- Price
- OKYO $1.37
- APYX $1.46
- Analyst Decision
- OKYO Strong Buy
- APYX Hold
- Analyst Count
- OKYO 1
- APYX 2
- Target Price
- OKYO $7.00
- APYX N/A
- AVG Volume (30 Days)
- OKYO 87.4K
- APYX 408.5K
- Earning Date
- OKYO 05-23-2025
- APYX 05-08-2025
- Dividend Yield
- OKYO N/A
- APYX N/A
- EPS Growth
- OKYO N/A
- APYX N/A
- EPS
- OKYO N/A
- APYX N/A
- Revenue
- OKYO N/A
- APYX $47,288,000.00
- Revenue This Year
- OKYO N/A
- APYX $1.85
- Revenue Next Year
- OKYO N/A
- APYX $7.72
- P/E Ratio
- OKYO N/A
- APYX N/A
- Revenue Growth
- OKYO N/A
- APYX N/A
- 52 Week Low
- OKYO $0.81
- APYX $0.76
- 52 Week High
- OKYO $1.74
- APYX $1.99
- Technical
- Relative Strength Index (RSI)
- OKYO 53.01
- APYX 60.13
- Support Level
- OKYO $1.32
- APYX $1.08
- Resistance Level
- OKYO $1.65
- APYX $1.76
- Average True Range (ATR)
- OKYO 0.11
- APYX 0.17
- MACD
- OKYO -0.01
- APYX 0.05
- Stochastic Oscillator
- OKYO 35.29
- APYX 62.57
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.